The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles

Gabriela M. Webb, Shengbin Li, Gwantwa Mwakalundwa, Joy M. Folkvord, Justin M. Greene, Jason S. Reed, Jeffrey Stanton, Alfred W. Legasse, Theodore Hobbs, Lauren Drew Martin, Byung Park, James B. Whitney, Emily K. Jeng, Hing C. Wong, Douglas F. Nixon, R. Brad Jones, Elizabeth Connick, Pamela J. Skinner, Jonah Sacha

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Sequestering of latent HIV in follicular helper T cells within B-cell follicles that largely exclude cytotoxic T cells is a major barrier to cellular immune-based approaches to eradicate HIV. Here, we show that the clinical-grade human interleukin-15 (IL-15) superagonist ALT-803 activates and redirects simian immunodeficiency virus (SIV)-specific CD8+ T cells from the peripheral blood into B-cell follicles. In agreement with the increased trafficking of SIV-specific cytotoxic T cells to sites of cryptic viral replication, lymph nodes of elite controlling macaques contained fewer cells expressing SIV RNA or harboring SIV DNA post-ALT-803 treatment. These data establish ALT-803 as an immunotherapeutic for HIV and other chronic viral pathogens that evade host immunity by persisting in B-cell follicles.

Original languageEnglish (US)
Pages (from-to)76-84
Number of pages9
JournalBlood advances
Volume2
Issue number2
DOIs
StatePublished - Jan 23 2018

Fingerprint

Simian Immunodeficiency Virus
B-Lymphocytes
T-Lymphocytes
HIV
Macaca
Helper-Inducer T-Lymphocytes
Immunity
Lymph Nodes
RNA
ALT-803
human IL15 protein
DNA

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles. / Webb, Gabriela M.; Li, Shengbin; Mwakalundwa, Gwantwa; Folkvord, Joy M.; Greene, Justin M.; Reed, Jason S.; Stanton, Jeffrey; Legasse, Alfred W.; Hobbs, Theodore; Martin, Lauren Drew; Park, Byung; Whitney, James B.; Jeng, Emily K.; Wong, Hing C.; Nixon, Douglas F.; Jones, R. Brad; Connick, Elizabeth; Skinner, Pamela J.; Sacha, Jonah.

In: Blood advances, Vol. 2, No. 2, 23.01.2018, p. 76-84.

Research output: Contribution to journalArticle

Webb, GM, Li, S, Mwakalundwa, G, Folkvord, JM, Greene, JM, Reed, JS, Stanton, J, Legasse, AW, Hobbs, T, Martin, LD, Park, B, Whitney, JB, Jeng, EK, Wong, HC, Nixon, DF, Jones, RB, Connick, E, Skinner, PJ & Sacha, J 2018, 'The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles', Blood advances, vol. 2, no. 2, pp. 76-84. https://doi.org/10.1182/bloodadvances.2017012971
Webb, Gabriela M. ; Li, Shengbin ; Mwakalundwa, Gwantwa ; Folkvord, Joy M. ; Greene, Justin M. ; Reed, Jason S. ; Stanton, Jeffrey ; Legasse, Alfred W. ; Hobbs, Theodore ; Martin, Lauren Drew ; Park, Byung ; Whitney, James B. ; Jeng, Emily K. ; Wong, Hing C. ; Nixon, Douglas F. ; Jones, R. Brad ; Connick, Elizabeth ; Skinner, Pamela J. ; Sacha, Jonah. / The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles. In: Blood advances. 2018 ; Vol. 2, No. 2. pp. 76-84.
@article{83afef11829c45bf87fb5382374a4051,
title = "The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles",
abstract = "Sequestering of latent HIV in follicular helper T cells within B-cell follicles that largely exclude cytotoxic T cells is a major barrier to cellular immune-based approaches to eradicate HIV. Here, we show that the clinical-grade human interleukin-15 (IL-15) superagonist ALT-803 activates and redirects simian immunodeficiency virus (SIV)-specific CD8+ T cells from the peripheral blood into B-cell follicles. In agreement with the increased trafficking of SIV-specific cytotoxic T cells to sites of cryptic viral replication, lymph nodes of elite controlling macaques contained fewer cells expressing SIV RNA or harboring SIV DNA post-ALT-803 treatment. These data establish ALT-803 as an immunotherapeutic for HIV and other chronic viral pathogens that evade host immunity by persisting in B-cell follicles.",
author = "Webb, {Gabriela M.} and Shengbin Li and Gwantwa Mwakalundwa and Folkvord, {Joy M.} and Greene, {Justin M.} and Reed, {Jason S.} and Jeffrey Stanton and Legasse, {Alfred W.} and Theodore Hobbs and Martin, {Lauren Drew} and Byung Park and Whitney, {James B.} and Jeng, {Emily K.} and Wong, {Hing C.} and Nixon, {Douglas F.} and Jones, {R. Brad} and Elizabeth Connick and Skinner, {Pamela J.} and Jonah Sacha",
year = "2018",
month = "1",
day = "23",
doi = "10.1182/bloodadvances.2017012971",
language = "English (US)",
volume = "2",
pages = "76--84",
journal = "Blood advances",
issn = "2473-9529",
publisher = "American Society of Hematology",
number = "2",

}

TY - JOUR

T1 - The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles

AU - Webb, Gabriela M.

AU - Li, Shengbin

AU - Mwakalundwa, Gwantwa

AU - Folkvord, Joy M.

AU - Greene, Justin M.

AU - Reed, Jason S.

AU - Stanton, Jeffrey

AU - Legasse, Alfred W.

AU - Hobbs, Theodore

AU - Martin, Lauren Drew

AU - Park, Byung

AU - Whitney, James B.

AU - Jeng, Emily K.

AU - Wong, Hing C.

AU - Nixon, Douglas F.

AU - Jones, R. Brad

AU - Connick, Elizabeth

AU - Skinner, Pamela J.

AU - Sacha, Jonah

PY - 2018/1/23

Y1 - 2018/1/23

N2 - Sequestering of latent HIV in follicular helper T cells within B-cell follicles that largely exclude cytotoxic T cells is a major barrier to cellular immune-based approaches to eradicate HIV. Here, we show that the clinical-grade human interleukin-15 (IL-15) superagonist ALT-803 activates and redirects simian immunodeficiency virus (SIV)-specific CD8+ T cells from the peripheral blood into B-cell follicles. In agreement with the increased trafficking of SIV-specific cytotoxic T cells to sites of cryptic viral replication, lymph nodes of elite controlling macaques contained fewer cells expressing SIV RNA or harboring SIV DNA post-ALT-803 treatment. These data establish ALT-803 as an immunotherapeutic for HIV and other chronic viral pathogens that evade host immunity by persisting in B-cell follicles.

AB - Sequestering of latent HIV in follicular helper T cells within B-cell follicles that largely exclude cytotoxic T cells is a major barrier to cellular immune-based approaches to eradicate HIV. Here, we show that the clinical-grade human interleukin-15 (IL-15) superagonist ALT-803 activates and redirects simian immunodeficiency virus (SIV)-specific CD8+ T cells from the peripheral blood into B-cell follicles. In agreement with the increased trafficking of SIV-specific cytotoxic T cells to sites of cryptic viral replication, lymph nodes of elite controlling macaques contained fewer cells expressing SIV RNA or harboring SIV DNA post-ALT-803 treatment. These data establish ALT-803 as an immunotherapeutic for HIV and other chronic viral pathogens that evade host immunity by persisting in B-cell follicles.

UR - http://www.scopus.com/inward/record.url?scp=85045771344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045771344&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2017012971

DO - 10.1182/bloodadvances.2017012971

M3 - Article

VL - 2

SP - 76

EP - 84

JO - Blood advances

JF - Blood advances

SN - 2473-9529

IS - 2

ER -